Breaking News Instant updates and real-time market news.

AGN

Allergan

$191.14

-0.64 (-0.33%)

07:36
11/22/16
11/22
07:36
11/22/16
07:36

Allergan receives FDA clearance for XEN Gel Stent

Allergan announced the U.S. FDA has cleared the XEN Glaucoma Treatment System for use in the U.S. The XEN Glaucoma Treatment System reduces intraocular pressure in patients and is indicated for the management of refractory glaucomas, where previous surgical treatment has failed or in patients with primary open angle glaucoma, and pseudoexfoliative or pigmentary glaucoma with open angles that are unresponsive to maximum tolerated medical therapy. XEN is implanted through an ab interno approach and reduces IOP by creating a new drainage channel with a permanent implant that becomes flexible. This provides a new treatment option for the millions of Americans with refractory glaucoma. Allergan plans to launch the XEN Glaucoma Treatment System in the U.S. in early 2017. More than 10,500 XEN Gel Stents have already been distributed worldwide. XEN is CE marked in the European Union, where it is indicated for the reduction of intraocular pressure in patients with primary open angle glaucoma where previous medical treatments have failed. It is also licensed for use in Canada, Switzerland, and Turkey.

  • 29

    Nov

AGN Allergan
$191.14

-0.64 (-0.33%)

11/03/16
LEER
11/03/16
NO CHANGE
Target $266
LEER
Outperform
Allergan price target lowered to $266 from $294 at Leerink
Leerink analyst Jason Gerberry lowered his price target for Allergan to $266 from $294 after the company reported quarterly results modestly missing revenue and EPS targets, with a slowdown in revenue for some of the company's established products leading to a 2016 guidance rebasing. However, Gerberry reiterates an Outperform rating on the shares as he came away from the quarter update encouraged by robust Q3 sales growth from Allergan's more differentiated/cash pay growth drivers.
11/04/16
UBSW
11/04/16
NO CHANGE
Target $240
UBSW
Buy
Allergan price target lowered to $240 from $300 at UBS
UBS analyst Marc Goodman lowered his price target on Allergan to $240 from $300 following disappointing Q3 results and a lowering of his estimates. However, Goodman reiterated his Buy rating on Allergan shares, on the belief it is still a good growth story, has an efficient tax structure and robust pipeline, and has the potential to put up double digit earnings growth for the rest of the decade.
11/21/16
WBLR
11/21/16
INITIATION
Target $209
WBLR
Market Perform
Allergan initiated with a Market Perform at William Blair
William Blair analyst Tim Lugo started Allergan with a Market Perform rating and $209 price target. The analyst views the company as high quality but sees headwinds in 2017 and 2018. Renewed competition for Botox could weigh on out-year estimates while a Namenda generic could come sooner than expected, Lugo tells investors in a research note.
11/21/16
11/21/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Netflix (NFLX) initiated with a Buy at Brean Capital. 2. Allergan (AGN) initiated with a Market Perform at William Blair. 3. Myovant Sciences (MYOV) was initiated with an Overweight at Barclays, an Outperform at JMP Securities, an Outperform at Baird, a Buy at Citi, and an Outperform at Cowen. 4. RA Pharmaceuticals (RARX) was initiated with a Buy at Jefferies, a Buy at SunTrust, and an Outperform at Credit Suisse. 5. ZTO Express (ZTO) was initiated with a Buy ratings at Citi and Goldman and an Overweight at Morgan Stanley. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.

TODAY'S FREE FLY STORIES

16:30
01/23/18
01/23
16:30
01/23/18
16:30
Options
Preliminary option volume of 22.5M today »

Preliminary option volume…

SBBP

Strongbridge Biopharma

$8.70

0.25 (2.96%)

16:27
01/23/18
01/23
16:27
01/23/18
16:27
Syndicate
Strongbridge Biopharma files to sell 5M shares of common stock »

JMP Securities is acting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TXN

Texas Instruments

$120.00

0.56 (0.47%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Technical Analysis
Technical Take: Texas Instruments drops sharply after results »

The shares were last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports Q4…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

JAX

J. Alexander's

$10.20

-0.3 (-2.86%)

16:26
01/23/18
01/23
16:26
01/23/18
16:26
Hot Stocks
J. Alexander's major holders support 99 Restaurants acquisition »

Substantial holders of J.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jan

TK

Teekay Corp.

$10.74

0.05 (0.47%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Syndicate
Teekay Corp. 10M share Spot Secondary; price range $9.75-$10.00 »

Morgan Stanley,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

COF

Capital One

$105.71

0.22 (0.21%)

16:25
01/23/18
01/23
16:25
01/23/18
16:25
Hot Stocks
Breaking Hot Stocks news story on Capital One »

Capital One reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

ROL

Rollins

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Rollins raises dividend 21.7% to 14c »

Rollins approved a 21.7%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Hot Stocks
Valero announces additional $2.5B share repurchase authorization »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

CMRE

Costamare

$6.16

-0.12 (-1.91%)

16:23
01/23/18
01/23
16:23
01/23/18
16:23
Earnings
Costamare reports Q4 EPS 17c, consensus 15c »

On January 23, 2018,the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

COF

Capital One

$105.71

0.22 (0.21%)

16:22
01/23/18
01/23
16:22
01/23/18
16:22
Hot Stocks
Capital One reports Q4 net interest margin 7.03%, down 5 bps »

Reports Efficiency ratio…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

VLO

Valero

$98.69

-0.26 (-0.26%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Hot Stocks
Valero increases dividend 14% »

The board of Valero…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Feb

COF

Capital One

$105.71

0.22 (0.21%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

UMPQ

Umpqua Holdings

$22.11

-0.18 (-0.81%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Breaking Earnings news story on Umpqua Holdings »

Umpqua Holdings reports…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jan

  • 13

    Mar

COF

Capital One

$105.71

0.22 (0.21%)

16:21
01/23/18
01/23
16:21
01/23/18
16:21
Earnings
Capital One reports Q4 adjusted EPS $1.62, consensus $1.88 »

Reports Q4 revenue $7B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

MULE

MuleSoft

$25.08

-0.31 (-1.22%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Initiation
MuleSoft initiated  »

MuleSoft initiated with a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

SIGM

Sigma Designs

$7.00

0.025 (0.36%)

, SLAB

Silicon Labs

$99.80

1.15 (1.17%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Hot Stocks
Sigma Designs to sell Z-Wave business to Silicon Labs for $240M »

Sigma Designs (SIGM)…

SIGM

Sigma Designs

$7.00

0.025 (0.36%)

SLAB

Silicon Labs

$99.80

1.15 (1.17%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jan

SCOR

comScore

$23.65

-0.1 (-0.42%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Periodicals
comScore working with Goldman on potential sale, Bloomberg reports »

comScore is working with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EQC

Equity Commonwealth

$30.37

0.33 (1.10%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Hot Stocks
Equity Commonwealth to sell two properties for $670M »

Equity Commonwealth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Feb

AUO

AU Optronics

$4.69

0.03 (0.64%)

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Upgrade
AU Optronics rating change  »

AU Optronics upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VIX

Volatility Index S&P 500 Options

16:20
01/23/18
01/23
16:20
01/23/18
16:20
Options
Closing CBOE SPX and VIX Index summary for January 23rd »

The CBOE Volatility Index…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPL

LG Display

$15.59

1.33 (9.33%)

16:19
01/23/18
01/23
16:19
01/23/18
16:19
Upgrade
LG Display rating change  »

LG Display upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NFLX

Netflix

$250.29

22.71 (9.98%)

, TRV

Travelers

$146.26

6.91 (4.96%)

16:19
01/23/18
01/23
16:19
01/23/18
16:19
General news
On The Fly: Top stock stories for Tuesday »

The Dow and S&P 500…

NFLX

Netflix

$250.29

22.71 (9.98%)

TRV

Travelers

$146.26

6.91 (4.96%)

VZ

Verizon

$53.23

-0.23 (-0.43%)

JNJ

Johnson & Johnson

$141.83

-6.31 (-4.26%)

PG

Procter & Gamble

$89.05

-2.84 (-3.09%)

TSLA

Tesla

$352.79

1.23 (0.35%)

DIS

Disney

$110.41

-0.69 (-0.62%)

JPM

JPMorgan

$114.21

-0.12 (-0.10%)

RMD

ResMed

$100.35

12.84 (14.67%)

WHR

Whirlpool

$171.98

5.33 (3.20%)

INSM

Insmed

$29.01

-1.855 (-6.01%)

TWTR

Twitter

$22.75

-0.57 (-2.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 23

    Jan

  • 25

    Jan

  • 25

    Jan

  • 30

    Jan

  • 06

    Feb

  • 07

    Feb

  • 07

    Feb

  • 08

    Feb

  • 16

    Feb

  • 27

    Feb

  • 28

    Feb

  • 08

    Mar

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.